Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Wolfe

Showing results (411-420 of 424) with videos related to

Pageof 43
Sort By:
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
Journal of the American Academy of Dermatology|October 28, 2022
Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology settingClaire Felmingham, Yan Pan, Yonatan Kok, et al.
JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.
Journal of the National Cancer Institute|August 12, 2020
Effect of Aspirin on Cancer Incidence and Mortality in Older AdultsJohn J McNeil, Peter Gibbs, Suzanne G Orchard, et al.
American Journal of Hypertension|December 7, 2019
Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional StudyEnayet K Chowdhury, Mark R Nelson, Michael E Ernst, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on Disability-free Survival in the Healthy ElderlyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyJohn J McNeil, Mark R Nelson, Robyn L Woods, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
Pageof 43

Showing results (411-420 of 424) with videos related to

Sort By:
Pageof 43
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
Journal of the American Academy of Dermatology|October 28, 2022
Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology settingClaire Felmingham, Yan Pan, Yonatan Kok, et al.
JAMA Oncology|January 29, 2026
Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE TrialSuzanne G Orchard, Galina Polekhina, John Zalcberg, et al.
Journal of the National Cancer Institute|August 12, 2020
Effect of Aspirin on Cancer Incidence and Mortality in Older AdultsJohn J McNeil, Peter Gibbs, Suzanne G Orchard, et al.
American Journal of Hypertension|December 7, 2019
Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional StudyEnayet K Chowdhury, Mark R Nelson, Michael E Ernst, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on Disability-free Survival in the Healthy ElderlyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyJohn J McNeil, Mark R Nelson, Robyn L Woods, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
Pageof 43